Clinical Performance of Hematological Indices as Predictors of Mortality in Patients with Severe Acute Pancreatitis of Biliary Origin in the General Hospital of Zone No. 3, of Aguascalientes, México
Main Article Content
Abstract
Background: Acute pancreatitis is a common disease with a potentially high mortality rate, making early risk assessment essential for optimizing treatment.
Objective: To evaluate the clinical performance of hematological indices as predictors of mortality in patients with severe acute biliary pancreatitis admitted to General Hospital Zone No. 3 in Aguascalientes.
Material and methods: An instrumental, retrospective, and observational study was conducted at General Hospital Zone No. 3 in Aguascalientes, Mexico, from January 1, 2023, to March 31, 2024. The study included 25 patients over 18 years of age diagnosed with severe acute biliary pancreatitis. Clinical and demographic data were extracted from medical records. The performance of each index was assessed using ROC curves, with sensitivity, specificity, and predictive values calculated at various cutoff points. Fagan's nomograms were used to interpret pre-test and post-test probabilities of mortality.
Results: Among the 25 patients evaluated, 36% died. The neutrophil-to-lymphocyte ratio (NLR) demonstrated the best performance as a mortality predictor, with an area under the curve (AUC) of 0.823. The optimal cutoff point was 15.1, with a sensitivity of 78% and a specificity of 88%, confirming its ability to distinguish between patients who died and those who survived. The red cell distribution width (RDW) had an AUC of 0.747, with high sensitivity (89%) but lower specificity (56%) at a cutoff of 15.0, making it a moderately effective predictor. Conversely, the platelet-to-lymphocyte ratio (PLR) performed poorly, with an AUC of 0.451, indicating low predictive value for mortality.
Conclusions: The neutrophil-to-lymphocyte ratio (NLR) emerged as the most effective predictor of mortality in this population of patients with severe acute biliary pancreatitis, followed by the red cell distribution width (RDW), which also showed moderate capability in predicting adverse outcomes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Dancu GM, Popescu A, Sirli R, Danila M, Bende F, Tarta C, et al. The BISAP score, NLR, CRP, or BUN: Which marker best predicts the outcome of acute pancreatitis? Medicine (Baltimore) [Internet]. 2021;100(51):e28121. Disponible en: http://dx.doi.org/10.1097/md.0000000000028121
II. Ríos Jaimes F, Villarreal Ríos E, Martínez González L, Vargas Daza ER, Galicia Rodríguez L, Ortiz Sánchez MC, et al. Índice clínico de gravedad en pancreatitis aguda como predictor de mortalidad en pancreatitis aguda en el servicio de urgencias. Rev Chil Cir [Internet]. 2017;69(6):441–5. Disponible en: http://dx.doi.org/10.1016/j.rchic.2017.06.005
III. Khan NA, Haider Kazmi SJ, Asghar MS, Singh M, Iqbal S, Jawed R, et al. Hematological indices predicting the severity of acute pancreatitis presenting to the emergency department: A retrospective analysis. Cureus [Internet]. 2021; Disponible en: http://dx.doi.org/10.7759/cureus.16752
IV. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut [Internet]. 2013;62(1):102–11. Disponible en: http://dx.doi.org/10.1136/gutjnl-2012-302779
V. Brooks, S. (2015, noviembre 5). Calculators. Select Statistical Consultants. https://select-statistics.co.uk/calculators/
VI. Arredondo GP, de Jesús Concha May A. Prevalencia de pancreatitis aguda en un Hospital General. Análisis de Cinco años [Internet]. Medigraphic.com. Disponible en: https://www.medigraphic.com/pdfs/salquintanaroo/sqr-2021/sqr2145e.pdf
VII. Ríos DFM, Meleros OMÁ, Ajá LT, Lorenzo JAP. Morbilidad y mortalidad en pacientes con pancreatitis aguda. Cienfuegos, 2014-2015. Medisur [Internet]. 2019;17(2):210–20. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/3830
VIII. Jinno N, Hori Y, Naitoh I, Miyabe K, Yoshida M, Natsume M, et al. Predictive factors for the mortality of acute pancreatitis on admission. PLoS One [Internet]. 2019;14(8):e0221468. Disponible en: http://dx.doi.org/10.1371/journal.pone.0221468
IX. Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol [Internet]. 2019 [citado el 9 de octubre de 2024];16(3):175–84. Disponible en: https://www.nature.com/articles/s41575-018-0087-5
X. González-González JA, Castañeda-Sepúlveda R, Martínez-Vázquez MA, García-Compean D, Flores-Rendón AR, Maldonado-Garza HJ, et al. Características clínicas de la pancreatitis aguda en México. Rev Gastroenterol Mex [Internet]. 2012;77(4):167–73. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0375090612001127
XI. Dobszai D, Mátrai P, Gyöngyi Z, Csupor D, Bajor J, Erőss B, Mikó A, Szakó L, Meczker Á, Hágendorn R, Márta K, Szentesi A, Hegyi P, on behalf of the Hungarian Pancreatic Study Group. Body-mass index correlates with severity and mortality in acute pancreatitis: A meta-analysis. World J Gastroenterol 2019; 25(6): 729-743 [PMID: 30783376 DOI: 10.3748/wjg.v25.i6.729]
XII. Ríos Jaimes F, Villarreal Ríos E, Martínez González L, Vargas Daza ER, Galicia Rodríguez L, Ortiz Sánchez MC, et al. Índice clínico de gravedad en pancreatitis aguda como predictor de mortalidad en pancreatitis aguda en el servicio de urgencias. Rev Chil Cir [Internet]. 2017;69(6):441–5. Disponible en: http://dx.doi.org/10.1016/j.rchic.2017.06.005
XIII. Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, et al. Global incidence of acute pancreatitis is increasing over time: A systematic review and meta-analysis. Gastroenterology [Internet]. 2022;162(1):122–34. Disponible en: http://dx.doi.org/10.1053/j.gastro.2021.09.043
XIV. Zhou H, Mei X, He X, Lan T, Guo S. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: A retrospective study. Medicine (Baltimore) [Internet]. 2019;98(16):e15275. Disponible en: http://dx.doi.org/10.1097/md.0000000000015275
XV. Junare PR, Debnath P, Nair S, Chandnani S, Udgirkar S, Thange R, et al. Complete hemogram: simple and cost-effective in staging and predicting outcome in acute pancreatitis. Wien Klin Wochenschr [Internet]. 2021;133(13–14):661–8. Disponible en: http://dx.doi.org/10.1007/s00508-021-01821-2
XVI. Gezer NS, Bengi G, Baran A, Erkmen PE, Topalak ÖS, Altay C, et al. Comparison of radiological scoring systems, clinical scores, neutrophil-lymphocyte ratio and serum C-reactive protein level for severity and mortality in acute pancreatitis. Rev Assoc Med Bras [Internet]. 2020;66(6):762–70. Disponible en: http://dx.doi.org/10.1590/1806-9282.66.6.762
XVII. Goyal H, Awad H, Hu Z-D. Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. Ann Transl Med [Internet]. 2017;5(17):342–342. Disponible en: http://dx.doi.org/10.21037/atm.2017.06.61
XVIII. Jain V, Nath P, Satpathy SK, Panda B, Patro S. Comparing prognostic scores and inflammatory markers in predicting the severity and mortality of acute pancreatitis. Cureus [Internet]. 2023; Disponible en: http://dx.doi.org/10.7759/cureus.39515.